About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Successfully Treated Post-urosurgical Urinary Tract Aspergillosis
Neha Gupta1, Ashima Jain Vidyarthi2, Prasun Ghosh3, Dheeraj Gautam4, Kulbir Ahlawat5, Rajeev Soman6
Departments of 1Internal Medicine, 3Kidney & Urology, 4Histopathology, 5Radiology Medanta Hospital, Gurugram, Haryana, Delhi; 2Department of Microbiology, AIIMS, Delhi; 6Department of Infectious Diseases, Jupiter Hospital, Pune, Maharashtra, India.
Corresponding Author:
Dr Ashima Jain Vidyarthi
Email: drashima.aiims@gmail.com
Received: 04-FEB-2021 Accepted: 10-JUN-2021 Published Online: 05-JUL-2021
DOI: http://dx.doi.org/10.17659/01.2021.0037
Abstract
Background: Fungal infections of the genitourinary tract were a rare entity till now. However, with the marked rise in invasive genitourinary procedures and advances in radiological and microbiological diagnostics, such infections are increasingly being reported. Case Report: We report a case of 59-year-old gentleman who presented with fever, acute kidney injury due to left hydroureteronephrosis following a double-J (D-J) ureteral stent. Nephroscopic removal of slough material showed amorphous material along with numerous septate fungal hyphae. Cultures grew Aspergillus flavus. He was treated initially with voriconazole for 2 months. However, he had a relapse after 3 months which was managed with amphotericin deoxycholate (AmB-d) and 5-flucytosine (5-FC). The patient responded well subsequently and has been keeping well during the 5-year follow up period. Conclusion: Successful outcome for post-urosurgical urinary tract aspergillosis depends upon a combined surgical and medical approach with good effective source control and appropriate mold-active antifungal agents. Good infection control practices need to be adequately emphasized.
Keywords : Acute Kidney Injury, Antifungal Agents, Aspergillus flavus, Aspergillosis, Hydronephrosis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024